Understanding cellular behavior at the molecular and systemic levels is crucial for advancing tissue-based therapeutics. Cell biology and stem cell engineering together explore how cells function, differentiate, and communicate, with the goal of manipulating these pathways for therapeutic gain. Innovations in reprogramming somatic cells into pluripotent states and engineering them to exhibit specific phenotypes are redefining regenerative interventions. Researchers are applying gene-editing techniques like CRISPR, optimizing signaling pathways, and tuning mechanical environments to guide differentiation into specialized cell types. The combination of bioengineering platforms and advanced imaging techniques allows for real-time tracking of engineered cells in complex environments. As challenges such as immune rejection and tumorigenicity are addressed, cell biology and stem cell engineering are moving closer to creating stable, safe, and scalable solutions. These advancements hold immense potential for treating neurological disorders, musculoskeletal injuries, and metabolic conditions by targeting cellular mechanisms directly.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy